Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization

Abstract Background Caffeine exposure modifies the turnover of monoamine neurotransmitters, which play a role in several neuropsychiatric disorders. We conducted a Mendelian randomization study to investigate whether higher plasma caffeine levels are causally associated with the risk of anorexia ner...

Full description

Bibliographic Details
Main Authors: Benjamin Woolf, Héléne T. Cronjé, Loukas Zagkos, Stephen Burgess, Dipender Gill, Susanna C. Larsson
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-023-03008-0
_version_ 1827634011029110784
author Benjamin Woolf
Héléne T. Cronjé
Loukas Zagkos
Stephen Burgess
Dipender Gill
Susanna C. Larsson
author_facet Benjamin Woolf
Héléne T. Cronjé
Loukas Zagkos
Stephen Burgess
Dipender Gill
Susanna C. Larsson
author_sort Benjamin Woolf
collection DOAJ
description Abstract Background Caffeine exposure modifies the turnover of monoamine neurotransmitters, which play a role in several neuropsychiatric disorders. We conducted a Mendelian randomization study to investigate whether higher plasma caffeine levels are causally associated with the risk of anorexia nervosa, bipolar disorder, major depressive disorder (MDD), and schizophrenia. Methods Summary-level data on the neuropsychiatric disorders were obtained from large-scale genome-wide association studies (GWASs) of European ancestry participants (n = 72,517 to 807,553) and meta-analyzed with the corresponding data from the FinnGen study (n = 356,077). Summary-level data on plasma caffeine were extracted from a GWAS meta-analysis of 9876 European ancestry individuals. The Mendelian randomization analyses estimated the Wald ratio for each genetic variant and meta-analyzed the variant-specific estimates using multiplicative random effects meta-analysis. Results After correcting for multiple testing, genetically predicted higher plasma caffeine levels were associated with higher odds of anorexia nervosa (odds ratio [OR] = 1.124; 95% confidence interval [CI] = 1.024–1.238, p FDR = 0.039) and a lower odds of bipolar disorder (OR = 0.905, 95% CI = 0.827–0.929, p FDR = 0.041) and MDD (OR = 0.965, 95% CI = 0.937–0.995, p FDR = 0.039). Instrumented plasma caffeine levels were not associated with schizophrenia (OR = 0.986, 95% CI = 0.929–1.047, p FDR = 0.646). Conclusions These Mendelian randomization findings indicate that long-term higher plasma caffeine levels may lower the risk of bipolar disorder and MDD but increase the risk of anorexia nervosa. These results warrant further research to explore whether caffeine consumption, supplementation, or abstinence could render clinically relevant therapeutic or preventative psychiatric effects.
first_indexed 2024-03-09T15:07:28Z
format Article
id doaj.art-045b80c6e72f4eab8f0f9f87bca751ba
institution Directory Open Access Journal
issn 1741-7015
language English
last_indexed 2024-03-09T15:07:28Z
publishDate 2023-08-01
publisher BMC
record_format Article
series BMC Medicine
spelling doaj.art-045b80c6e72f4eab8f0f9f87bca751ba2023-11-26T13:33:50ZengBMCBMC Medicine1741-70152023-08-012111810.1186/s12916-023-03008-0Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomizationBenjamin Woolf0Héléne T. Cronjé1Loukas Zagkos2Stephen Burgess3Dipender Gill4Susanna C. Larsson5School of Psychological Science, University of BristolDepartment of Public Health, Section of Epidemiology, University of CopenhagenDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College LondonMRC Biostatistics Unit at the University of CambridgeDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College LondonUnit of Medical Epidemiology, Department of Surgical Sciences, Uppsala UniversityAbstract Background Caffeine exposure modifies the turnover of monoamine neurotransmitters, which play a role in several neuropsychiatric disorders. We conducted a Mendelian randomization study to investigate whether higher plasma caffeine levels are causally associated with the risk of anorexia nervosa, bipolar disorder, major depressive disorder (MDD), and schizophrenia. Methods Summary-level data on the neuropsychiatric disorders were obtained from large-scale genome-wide association studies (GWASs) of European ancestry participants (n = 72,517 to 807,553) and meta-analyzed with the corresponding data from the FinnGen study (n = 356,077). Summary-level data on plasma caffeine were extracted from a GWAS meta-analysis of 9876 European ancestry individuals. The Mendelian randomization analyses estimated the Wald ratio for each genetic variant and meta-analyzed the variant-specific estimates using multiplicative random effects meta-analysis. Results After correcting for multiple testing, genetically predicted higher plasma caffeine levels were associated with higher odds of anorexia nervosa (odds ratio [OR] = 1.124; 95% confidence interval [CI] = 1.024–1.238, p FDR = 0.039) and a lower odds of bipolar disorder (OR = 0.905, 95% CI = 0.827–0.929, p FDR = 0.041) and MDD (OR = 0.965, 95% CI = 0.937–0.995, p FDR = 0.039). Instrumented plasma caffeine levels were not associated with schizophrenia (OR = 0.986, 95% CI = 0.929–1.047, p FDR = 0.646). Conclusions These Mendelian randomization findings indicate that long-term higher plasma caffeine levels may lower the risk of bipolar disorder and MDD but increase the risk of anorexia nervosa. These results warrant further research to explore whether caffeine consumption, supplementation, or abstinence could render clinically relevant therapeutic or preventative psychiatric effects.https://doi.org/10.1186/s12916-023-03008-0Anorexia nervosaBipolar disorder caffeineCoffeeDepressionMendelian randomizationSchizophrenia
spellingShingle Benjamin Woolf
Héléne T. Cronjé
Loukas Zagkos
Stephen Burgess
Dipender Gill
Susanna C. Larsson
Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
BMC Medicine
Anorexia nervosa
Bipolar disorder caffeine
Coffee
Depression
Mendelian randomization
Schizophrenia
title Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
title_full Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
title_fullStr Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
title_full_unstemmed Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
title_short Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
title_sort appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through mendelian randomization
topic Anorexia nervosa
Bipolar disorder caffeine
Coffee
Depression
Mendelian randomization
Schizophrenia
url https://doi.org/10.1186/s12916-023-03008-0
work_keys_str_mv AT benjaminwoolf appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization
AT helenetcronje appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization
AT loukaszagkos appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization
AT stephenburgess appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization
AT dipendergill appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization
AT susannaclarsson appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization